AU476373B2 - New 3, 4-dihydropyridones, their production, and their medicinal use - Google Patents

New 3, 4-dihydropyridones, their production, and their medicinal use

Info

Publication number
AU476373B2
AU476373B2 AU59835/73A AU5983573A AU476373B2 AU 476373 B2 AU476373 B2 AU 476373B2 AU 59835/73 A AU59835/73 A AU 59835/73A AU 5983573 A AU5983573 A AU 5983573A AU 476373 B2 AU476373 B2 AU 476373B2
Authority
AU
Australia
Prior art keywords
dihydropyridones
new
production
medicinal use
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU59835/73A
Other languages
English (en)
Other versions
AU5983573A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU5983573A publication Critical patent/AU5983573A/en
Application granted granted Critical
Publication of AU476373B2 publication Critical patent/AU476373B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
AU59835/73A 1972-08-31 1973-08-30 New 3, 4-dihydropyridones, their production, and their medicinal use Expired AU476373B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEDE822427 1972-08-31
DE2242787A DE2242787C2 (de) 1972-08-31 1972-08-31 4-Phenyl-6-amino-3,4-dihydropyridon-(2)-3,5-dicarbonsäure-diäthylesterderivate, ein Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
AU5983573A AU5983573A (en) 1975-03-06
AU476373B2 true AU476373B2 (en) 1976-09-16

Family

ID=5855065

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59835/73A Expired AU476373B2 (en) 1972-08-31 1973-08-30 New 3, 4-dihydropyridones, their production, and their medicinal use

Country Status (21)

Country Link
US (1) US3925395A (OSRAM)
JP (1) JPS5626661B2 (OSRAM)
AT (1) AT327902B (OSRAM)
AU (1) AU476373B2 (OSRAM)
BE (1) BE804161A (OSRAM)
CA (1) CA1016946A (OSRAM)
CH (1) CH592061A5 (OSRAM)
DD (1) DD109628A5 (OSRAM)
DE (1) DE2242787C2 (OSRAM)
DK (1) DK131855C (OSRAM)
ES (1) ES418340A1 (OSRAM)
FR (1) FR2197598B1 (OSRAM)
GB (1) GB1389505A (OSRAM)
HU (1) HU167992B (OSRAM)
IE (1) IE38141B1 (OSRAM)
IL (1) IL43080A (OSRAM)
LU (1) LU68325A1 (OSRAM)
NL (1) NL7311832A (OSRAM)
PL (1) PL89430B1 (OSRAM)
SE (1) SE385882B (OSRAM)
ZA (1) ZA735973B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002762A (en) * 1973-03-03 1977-01-11 Bayer Aktiengesellschaft 2-Amino-3,4-dihydropyridines used to effect coronary vessel dilation and treat hypertension
IT8367883A0 (it) * 1982-08-23 1983-08-22 Rorer Int Overseas Composti cardiotonici del 2 piridone 5 biciclico eteroaril sostituito e relative composizioni farmaceutiche
WO1993009774A1 (en) * 1991-11-18 1993-05-27 G.D. Searle & Co. 2-(4-substituted)phenylmethylene derivatives and methods of use
CA2496815C (en) 2002-08-27 2011-04-26 Bayer Healthcare Ag Dihydropyridinone derivatives
US20050252833A1 (en) * 2004-05-14 2005-11-17 Doyle James A Process and apparatus for converting oil shale or oil sand (tar sand) to oil

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
DE2003146A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate

Also Published As

Publication number Publication date
CA1016946A (en) 1977-09-06
PL89430B1 (OSRAM) 1976-11-30
FR2197598B1 (OSRAM) 1977-07-15
ES418340A1 (es) 1976-03-16
IE38141B1 (en) 1978-01-04
GB1389505A (en) 1975-04-03
DK131855B (da) 1975-09-15
DE2242787A1 (de) 1974-03-14
HU167992B (OSRAM) 1976-02-28
BE804161A (fr) 1974-02-28
IL43080A (en) 1977-01-31
JPS5626661B2 (OSRAM) 1981-06-19
ZA735973B (en) 1974-10-30
US3925395A (en) 1975-12-09
AU5983573A (en) 1975-03-06
FR2197598A1 (OSRAM) 1974-03-29
IL43080A0 (en) 1973-11-28
DD109628A5 (OSRAM) 1974-11-12
ATA760073A (de) 1975-05-15
IE38141L (en) 1974-02-28
AT327902B (de) 1976-02-25
DK131855C (da) 1976-02-16
SE385882B (sv) 1976-07-26
JPS4962483A (OSRAM) 1974-06-17
LU68325A1 (OSRAM) 1973-10-30
CH592061A5 (OSRAM) 1977-10-14
DE2242787C2 (de) 1982-01-21
NL7311832A (OSRAM) 1974-03-04

Similar Documents

Publication Publication Date Title
AU473996B2 (en) New 1, 4-dihydropyridines, their production, and their medicinal use
AU475802B2 (en) New 1-phenyl-substituted 1,3,5-triazines, their production, and their medicinal use
AU476129B2 (en) New dihydropydridine polyesters their production and their medicinal use
ZA731504B (en) New bridgehead-heterocyclic compounds,their production and their medicinal use
AU464773B2 (en) BENZO-l, 2, 4-TRIAZINE-l, 4-DIN-OXIDES THEIR PRODUCTION, AND THEIR MEDICAL USE
CA930365A (en) Aminophenylamidines, their production and their medicinal use
AU470790B2 (en) New 2-amino-1, 4-dihydropyridines, their production, and their medicinal use
AU471621B2 (en) New 1-ethyl-imidazoles, their production, and their medicinal use
CA942312A (en) Aminophenyl-cycloamidines, their production and their medicinal use
AU469267B2 (en) New 2-alkylamino-dihydropyridines, their production and their medicinal use
KR780000119B1 (en) New 2.6-diamino-dihydropyridines, their production, and their medicinal use
AU5983573A (en) New 3, 4-dihydropyridones, their production, and their medicinal use
AU468904B2 (en) New 2-amino-4 h-pyrane compounds, their production, and their medicinal use
ZA742381B (en) New-1-substituted pyrazol-5-sones, their production and their medicinal use
AU475884B2 (en) New amidophenylisothioureas, their production, and their medicinal use
AU476155B2 (en) New 2, 6-diamino-dihydropyridines, their production and their medicinal use
ZA738075B (en) Phenylguanidin-derivatives,their production and their medicinal use
ZA731502B (en) New substituted 4,5-dihydropyridines,their production and their medicinal use
AU476612B2 (en) New benzoylphenylisothioureas, their production, and their medicinal use
AU474624B2 (en) New bridgehead-heterocyclic compounds, their production and their medicinal use
AU5287273A (en) New substituted 4,5-dihydropyridines, their proudction and their medicinal use
CA890925A (en) 1,3,4-thiadiazines and production thereof
AU448290B2 (en) New aminophenylamidines, their production and their medicinal use
CA904349A (en) Diphenylethylenediamines and their production and use
AU467854B2 (en) New substituted 4,5-dihydropyridines, their proudction and their medicinal use